CHARACTERISTICS OF FILGOTINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS WHO ACHIEVE SUSTAINED CORTICOSTEROID-FREE REMISSION: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Taku Kobayashi  1     Axel Dignass  2     Xavier Roblin  3     Yasushi Fujitani  4     Corinne Jamoul  5     Toshifumi Hibi  5    
1 Kitasato University Kitasato Institute Hospital, Tokyo, Japan
2 Agaplesion Markus Krankenhaus, Frankfurt/ Main, Germany
3 University Hospital of Saint-Étienne, Saint-Étienne, France
4 Gilead Sciences K.K., Tokyo, Japan
5 Galapagos NV, Mechelen, Belgium

Topic
IBD

Session
IBD: We treat them all - but how? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing